Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field ACETAZOLAMIDE
Renal · Renal · Level 3
HYDROCHLOROTHIAZIDE
Renal · Renal · Level 3
Mechanism of action

Diuresis
Reversible, non-competitive inhibitor of carbonic anhydrase
PCT: ↓H+ and HCO3- prodn
↓ cytosol H+ → ↓Na+ reabs in PCT→ ↑H2O loss
↓cytosol HCO3→↑luminal HCO3→ H2O diffusion with HCO3 ,Na, K to urine
Eye: ↓Na pump, ↓AH formation

inhibit Na+ reabsorption in the early portion of the distal tubule by
blocking the Na+.Cl- symporter in the apical membrane of these cells. Naturesis
occurs with thiazide diuretics is 5-10% of the filtered load

Physiological effects

Metabolic: Acidosis via ↑ excretion of bicarb (and reabsorption of Cl)
Resp: ↑MV → comp resp alk
CNS: anticonvulsant properties, ↓ CSF and IOP by ↓d formation GIT: ↓ Pancreatic and gastric
GU: mild diuresis, Na retention

Anti-HTN: (↓TPR, ↓plasma volume)
↓RBF → ↓GFR
↓K+,Na+,Mg.
Hyperchloremic MA
↑Ca++ (↓excretion)
↑Glu: (↓glycogenolysis, ↓insulin)

Absorption

IV/PO
PO BA = 100%

PO- BA ~50-80%. Onset 2hrs Dur 6-12hrs.

Distribution

Lip sol: crosses BBB

—
Protein binding

70-90%

68%

Volume of distribution —

3.6-7.8L/kg

Metabolism

Not metabolised

Not metabolized

Excretion

Unchanged in urine

Urine (unchanged)

Half-life

6-9hrs

5.6-14.8hrs

Adverse Effects Toxicity

metabolic acidosis, urinary alkalinisation, parathesias, fatigue,
hypokalaemia, N+V, abdo pain

Tox: Rashes, renal stones

↓K+/Na+/Mg++, ↑Ca++/urea/glu/chol.
indiosyncratic blood
dyscrasias. Rash, photsensitivity. Interactions may prolong action of NDMBs. NSAIDs antagonise the action

Class Group

Diuretic – Carbonic Anhydrase Inhibitor

Diuretic - Thiazide

Indications Uses

Glaucoma
Miniere’s disease
Altitude sickness
Adjunct in epilepsy

heart failure and hypertension. Used in combination. mostly bound to plasma prot, and gain access to the tubule via secretion in the PCT.

Introduction

Sulfonamide

related to the sulphonamides

Legacy Cicm Level

Level 3

Level 3

Presentation

250mg white tablets
500mg vials for reconstitution

orange scored tablets of 25mg and combos

Route And Dose

250-1000mg q6hrly
IV/PO

PO. 12.5-200mg/day